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Case
A 76-year-old man with no significant past medical history 
presented with a two month history of progressive shortness 
of breath, 25-pound weight loss, and sharp right-sided chest, 
abdomen, and pelvic pain without radiation. The patient noted 
his dyspnea became more pronounced in recent weeks, notably 
worse with climbing stairs or performing work around the 
house. He described the pain as having a positional component, 
and exacerbated with deep-inspiration. On further questioning, 
the patient reported a 50-pack-year history of smoking and past 
exposure to asbestos while working with heating insulation. 
Physical examination revealed an age-appropriate, but cachectic 
appearing male with tenderness of the right abdomen to 
palpation, mild tachypnea with 95% oxygen saturation on two 
liters of oxygen, and normal cardiac rate and rhythm. Initial 
chest radiograph revealed a large mass causing near complete 
opacification of the right hemithorax (Figure 1) which was a new 
finding compared to the patient’s previous chest radiograph two 
years prior (Figure 2). Computed tomography (CT) scan of the 
chest/abdomen/pelvis performed to further evaluate this mass 
(Figure 3) revealed a 20 x 21 x 23 cm heterogeneous tumor above 
the right hemidiaphragm with extension into the left atrium via 
the right pulmonary vein (white arrow), as well as lateral and 
anterior diaphragmatic and pleural involvement. Differential 
diagnosis at this stage included malignant mass, benign pleural 
wall tumor, and mesothelioma. Pathology from surgical biopsy 
(Figure 4) suggested Sarcomatoid mesothelioma. 
Mesothelioma is an aggressive, rare malignancy arising from 
mesothelial cells, most commonly in the pleura, but also noted to 
occur in the peritoneum, pericardium, or tunica vaginalis. Three 
major histologic subtypes of mesothelioma, epithelioid (most 
common), biphasic, and sarcomatoid, have been described. 
Accounting for only 10% of pleural malignant mesotheliomas, 
Sarcomatoid is the least common, defined by the absence of 
epithelial elements in biopsy material (Figure 4). Like other 
mesotheliomas, Sarcomatoid is most common in men older 
than 55, and is strongly associated with distant exposure to 
asbestos (particularly amphibole asbestos). Common presenting 
symptoms of all malignant pleural masses include dyspnea, 
weight loss, anorexia, night sweats and weakness.
Sarcomatoid type, the most aggressive subtype, shows the least 
response to surgery, chemotherapy, or radiation therapy. With 
a median survival near 6 months, Sarcomatoid mesothelioma is 
associated with a particularly poor prognosis compared to 12-24 
months for epithelial mesothelioma and 12 months for biphasic 
mesothelioma. Given his poor prognosis, our patient was offered 
palliative chemotherapy; however, after much discussion, he 
decided to forgo any therapy and was discharged home under 
the care of his family.
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Figure 1. Chest radiograph (PA) shows a mass in the right thorax 
causing left deviation of midline structures
Figure 2. Chest radiograph from two years prior to current 
admission is unremarkable for any lesion or mass
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Figure 3. Choronal computed tomography (CT) of the abdomen/
pelvis with reconstruction shows a circumscribed loculated mass 
with extension into the left atrium via right pulmonary vein 
(white arrow)
Figure 4. Hematoxylin & Eosin stained biopsy of right lung mass 
obtained by Trucut core needle biopsy shows absence of epithelial 
elements
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